![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
我们应该在什么时候使用它? 布伦图西马布维多丁在2024年的作用
Joseph G Schroers-Martin1, Ranjana Advani1
1Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA.
Hematology. American Society of Hematology. Education Program
|December 7, 2024
概括
布伦图西马布维多丁 (BV) 是对经典霍奇金淋巴瘤 (cHL) 的一项成熟治疗方法. 本综述探讨了BV在新免疫疗法和针对最佳患者使用的持续研究中不断变化的作用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 免疫疗法是一种免疫疗法.
背景情况:
- 布伦图西马布维多丁 (BV) 是FDA批准的针对经典霍奇金淋巴瘤 (cHL) 的抗体-药物结合剂.
- 乙维对复发性cHL,移植后维护和前线治疗有迹象.
- 对于cHL的治疗场景正在迅速发展,新型药物正在出现.
研究的目的:
- 审查布伦图西马布维多丁在CHL管理中的既定和不断变化的作用.
- 讨论新型免疫疗法对BV已确定的适应症的影响.
- 突出正在进行的研究,确定在cHL中最佳的BV使用.
主要方法:
- 临床试验和关于brentuximab vedotin在cHL中的研究的文献综述.
- 分析当前的治疗指南和新兴的治疗选择.
- 讨论正在进行的临床试验,在各种cHL环境中调查BV.
主要成果:
- 布伦图西马布维多丁已经证明了对cHL的不同疗法的有效性.
- 检查点抑制剂免疫疗法正在成为BV的重要竞争对手.
- 需要进行进一步的研究,以确定BV在新治疗的背景下所扮演的确切角色.
结论:
- 布伦图西马布维多丁 (Brentuximab vedotin) 仍然是CHL治疗中的一个有价值的药物.
- 它的最佳使用需要与免疫疗法等新疗法一起仔细考虑.
- 目前正在进行的研究旨在完善BV在cHL治疗模式中的地位.
更多相关视频
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.3K
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:30Cancer Vaccines
338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338